Clinical Trial Update: S0329, Gemcitabine and Paclitaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial S0329 evaluating gemcitabine and paclitaxel in patients with persistent, recurrent, or metastatic head and neck cancer has completed and posted re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Gemzar (gemcitabine)
• Taxol (paclitaxel)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Head and Neck Cancer | Phase 2 | Status: COMPLETED | Results posted: 2012-10-01